Trial Profile

A multi-center, placebo-controlled, double blind multiple-ascending dose study in a leapfrog design to investigate the safety, tolerability, pharmacodynamics and pharmacokinetics of RO5024118 following repeated inhalation in patients with moderate-to-severe Chronic Obstructive Pulmonary Disease.

Status: Withdrawn prior to enrolment

Phase of Trial: Phase I

Latest Information Update: 03 Nov 2016

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

26 Oct 2016 Status changed from completed to withdrawn prior to enrolment.
25 Mar 2010 Status changed from recruiting to completed as reported by Roche record.
18 Feb 2010 Planned number of patients changed from 30 to 35 as reported by ClinicalTrials.gov.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com